Advertisement

Reactions Weekly

, Volume 1760, Issue 1, pp 2–2 | Cite as

DOACs: increased risk of recurrent thrombotic events

News item
  • 63 Downloads

Reference

  1. Medicines and Healthcare products Regulatory Agency (UK). Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome. Drug Safety Update 12: 2-3, No. 11, Jun 2019. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/810191/June-2019-DSU-PDF.pdf

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations